STUDIES ON THE MODE OF ANTIFUNGAL ACTION OF PRADIMICIN ANTIBIOTICS I. LECTIN-MIMIC BINDING OF BMY-28864 TO YEAST MANNAN IN THE PRESENCE OF CALCIUM
TOMOKAZUUEKI, KEI-ICHI NUMATA, YOSUKE SAWADA, TASUKU NAKAJIMAt,
Yasuo Fukagawa and Toshikazu Oki
Bristol-Myers Squibb Research Institute, 2-9-3 Shimo-meguro, Meguro-ku, Tokyo 153, Japan 1 Tohoku University, Department of Applied Biochemistry, Sendai, Japan (Received for publication June 30, 1992) BMY-28864(BMS-181 184), a water-soluble pradimicin derivative, specifically bound on the yeast cell surface in the presence of calcium, which was considered to be the initial step that triggered chain reactions leading to the fungicidal action. Close cause-effect relationships of the cell wall binding of BMY-28864with its antifungal activity and potassium leakage induction were observed by Candida albicans and Saccharomyces cerevisiae in the presence and absence of calcium. Using mannanand methyl a-D-mannopyranoside as specific sugars, the modeof binding of BMY-28864to sugar was examined in vitro in the presence of calcium. Quantitative component analysis revealed that the precipitate of BMY-28864with methyl a-D-mannopyranoside and calcium was a ternary complex possessing a molar component ratio of 2.1 : 4.3 : 1.0. These findings altogether proved that BMY-28864, although not protein, recognized specific sugars such as mannose in the same manner as lectin, and that the ternary complex formation of BMY-28864with specific sugar and calcium was the first step for expression of the selective antifungal action of the pradimicin.
Pradimicins and benanomicins, which are antifungal and antiviral antibiotics produced by actinomycetes,1~3) belong to a recently discovered family of benzo [<z] naphthacenequinone compounds represented by chemical structures in Fig. 1 .4'5) They are selectively antifungal and antiviral without significant acute toxicity in mice as well as antibacterial activity on Gram-positive and Gramnegative bacteria. 4'6) Considered from their selective antifungal and antiviral activity profiles and no antifungal cross resistance with 5-fiuorocytosine, ketoconazole and amphotericin B,6'7) this family of antibiotics were assumed to have a novel mode of antifungal action. In previous papers,8~10) the anticandidal activities of pradimicin A and BMY-28864were reported to depend on their abundant adsorption on the cell wall of Candida albicans in the presence of calcium ion. Consequently the detailed study on (Benanomicin B) (R) JAN. 1993 the mechanismof antifungal action of pradimicins using a representative derivative was considered to be essential from the biochemical and clinical viewpoints, particularly because a new antifungal agent with a novel action mode has been eagerly sought for in clinical therapy of fungal infections in AIDS patients. For this purpose, BMY-28864,which is a hydrophilic derivative semi-synthesized from pradimicin FA-2,1 1} was selected among a variety of pradimicin derivatives, as it is expected to be of clinical interest based on its potent antifungal activity, good water-solubility and least cytotoxicity. 12) This paper describes that the antifungal action of BMY-28864began with lectin-mimic specific binding of the pradimicin to cell wall mannan which depended on the formation ofa ternary complex ofBMY-28864 with mannan and calcium.
Materials and Methods

Yeasts, Fungi, Bacteria and MannanPreparations
Candida albicans A9540 and Saccharomyces cerevisiae ATCC9763 were cultivated at 28°C for 24 hours under shaking in 500ml Erlenmeyer flasks containing 100 ml each of YPD medium (1 % yeast extract, 2% polypeptone and 2% glucose). Saccharomyces cerevisiae X2180-1A (wild type) and X2180-1A5-mnn2((l ->2)-mannosyl transferase II-defective strain) were gifts from Dr. C. E. Ballou.13>14) Other microbes were cultured and assayed as described before.8'9) Linear and branched polymannosaccharide preparations employed in Table 5 were prepared from a-l,6-mannan13) and wild type mannan by partial acetolysis as reported elsewhere. 13'15) Antimicrobial Assays MIC was determined by the agar dilution method on YNB(Difco)+glucose+PB agar medium, pH 7.0, in the presence and absence of 200fiM calcium chloride for fungi; and on nutrient agar mediumin the presence of 1 him calcium chloride for bacteria.
Adsorption to Freeze-dried Cells Adsorption of BMY-28864 was measured by incubating freeze-dried cells (1.0 mg for fungi, and 5 mg for bacteria) with 60 /ig/ml BMY-28864 HC1 for 30 minutes at 30°C in the presence and absence of 200 jum calcium chloride in 1 ml of50 mMsodium phosphate, pH 7.0. After incubation, the mixtures were centrifuged at 5,000 rpm for 5 minutes to provide the supernatants and the cells. The amount of BMY-28864 adsorbed to the cells was calculated by subtracting the absorbance reading of the test supernatant at 498.4 nm from that of the no-cell control.
Adsorption to Intact Candida Cells After 24 hours' cultivation in the YPDmedium, Candida albicans A9540 cells were harvested at 4°C by centrifugation at 3,000 rpm for 10 minutes; and rinsed twice in physiological saline. A mixture containing 5x 107 yeast cells, 100fi\ of l.lOmM BMY-28864 HC1, 10^1 of a 100mMmetal chloride solution and 890[A of physiological saline was incubated for 2hours at 30°C. After centrifugation at 5,000rpm for 5 minutes at 4°C, the supernatant was employed for determination of the potassium content by atomic absorption spectrometry. The control tests with and without BMY-28864contained no metal chloride.
For determination of BMY-28864adsorbed to cells, the intact cells were collected by centrifugation and rinsed twice in physiological saline, followed by suspension in 1 ml ofDMSOso that all the BMY-28864 adsorbed to the cells might be released into DMSO. The concentration of BMY-28864in the DMSO solution was read at 498.4 nm by UV/visible spectrophotometry (Beckman DU-70), and the difference in absorbance of the test from the no-metal chloride control gave the amount of BMY-28864adsorbed to the cells.
The total amount of potassium in the intact cells was recovered by boiling the cells at 100°C for 10minutes. Centrifugation of the boiled cells yielded the supernatant which was subjected to atomic absorption spectrometry. (T 8642) , chymotrypsin (C 3142) and alkaline phosphatase (P 8639) were purchased from Sigma Chemical Co.
Cell wall component or an enzyme was dissolved in 1ml (final volume) of 50him MOPS (3-(6-[iV-morpholino] Antifungal activity of BMY-28864against Saccharomyces cerevisiae was assayed by the agar well diffusion method on MAagar medium (agar 1.3%, sodium glutamate 0.15%, glucose 0.1%, MgSO4à" 7H2O 0.02%, NaCl 0.01% and biotin 0.00025% in 0.8mM phosphate+ 100mM MOPS, pH 7.2, containing 1 mM CaCl2). Sugar solution in 100mM MOPS, pH 7.2 (80jul; varied concentrations) , and 105 /xm BMY-28864 (20 fil) were mixed and subjected to the agar diffusion assay using Saccharomyces cerevisiae as tester. After incubation at 28°C for 20hours, the diameters of the inhibition zones were measured, and the 50% antagonistic concentration of a sugar was read from the dose-halo calibration curve.
Protective Effects of Mannanand Methyl a-D-Mannopyranoside (Me-Man) on Candida albicans
Protoplasts in the Presence of BMY-28864 Intact Candida albicans cells were transformed to protoplasts by the method of I. Takano and K. Arima. i lA8) More particularly, Candida albicans A9540 was cultivated at 28°C for 24 hours in YPDmedium and then harvested at 4°C by centrifugation at 1,500 rpm for 10minutes. The cell pellet was washed twice with physiological saline and preincubated at 30°C for 30minutes in 60mMEDTA, pH 7.0, containing 0.2% mercaptoethanol. The treated yeast cells were recovered by centrifugation and suspended at a density of 107cells/ml in 0.6m KC1 containing 0.2% mercaptoethanol. Zymolase 100T (Catalog No. 120493; Seikagaku Kogyo Co., Ltd) was added to the cell suspension at a final concentration of 20/ig/ml and incubated at 30°C for 60 minutes. The protoplasts were recovered by mild centrifugation and washed twice with 0.6m KC1. The protective effects of O.l mg/ml mannanand 100mMMe-Manwere observed by incubating the protoplasts (107 cells/ml) and 50^g/ml (55 /*m) BMY-28864 HC1 at 30°C for the indicated periods of time in NS medium (SDMmedium19) in which the sorbitol was replaced with 0.6m KC1). By JAN. 1993 centrifugation at 1,500 rpm and 4°C for 5 minutes, the protoplasts were recovered and resuspended in 1 ml of 0.6 m KC1 containing 100mMethylene glycol-fe-(j8-aminoethyl ether) JV,iV,iV',JV'-tetraacetic acid (EGTA), pH 7.0. After incubation at 30°C for 15minutes, the numbers of protoplasts were counted with a hemocytometer before and after dilution with water so that the count of the protoplasts was obtained as balance between the two observed numbers of cells.
Interaction of BMY-28864with Hexoses (1) Precipitation of BMY-28864with hexoses at 1 him calcium chloride. Hexoses were dissolved in 0.6m KC1, 50mMMOPS, pH 7.4, and distilled water (adjusted to pH 7.0), and then mixed with 136/ig/ml (final concentration, 150/^m) BMY-28864à"HC1. The final sugar concentrations were all set at 200 mM.After incubation at 30°C for 30 minutes, the reaction mixtures were centrifuged at 5,000 rpm for 5 minutes and the concentrations of BMY-28864remaining in the supernatants were spectrophotometrically read at 498.4nm. If a hexose precipitated with BMY-28864,the amount of BMY-28864 adsorbed to that hexose was calculated by subtracting the absorbance reading at 498.4nm of the supernatant from that of the no-sugar control. (1 mg) of freeze-dried cells were incubated at 30°C for 30minutes. The control test contained no specific sugar. After centrifugation at 14,000 rpm for 5 minutes, the precipitates were collected and washed twice with 1 ml each of 50 mMMOPSbuffer, pH 7.0. The BMY-28864-calcium-sugar precipitates were dissolved in 1 ml of DMSOand the optical density of the DMSOsolution was read at 498.4nm for determination of the BMY-28864 content.
Kinetics of Inhibition by Me-Manof BMY-28864Adsorption to Immobilized Saccharomyces cerevisiae Cells in the Presence of 1 mMCalcium Chloride Inhibitory effect of 50mMMe-Man on BMY-28864adsorption was kinetically examined by mixing 6.8 x 107 cells (2mg) of immobilized Saccharomyces cerevisiae cells with BMY-28864 (concentrations indicated in Fig. 4 ) at 1 mMof calcium chloride in a total volume of 8ml, followed by incubation at 30°C for 30 minutes. After centrifugation and rinsing, the cells were suspended in 1 ml DMSO. The supernatant was collected by centrifugation and the content of BMY-28864 was measured by UV/visible spectrophotometry at 498.4 nm.
Quantitative Component Analysis of the BMY-28864-sugar-calcium Complex (1) Molar ratio of BMY-28864to calcium in complexes containing a variety of specific sugars. A variety of sugars (500/il; final concentrations 200mM), 100/il of l.lOmM BMY-28864, 100^1 of 10mMCaCl2 and 300/il of distilled water were mixed and incubated at 30°C for 30minutes. The control contained no calcium chloride. The mixtures were centrifuged at 14,000rpm for 5minutes, and the precipitates, if formed, were recovered and washed three times with the corresponding sugar solutions at 200mM.The washed precipitates were dissolved in 1.0ml DMSOand divided into halves which were employed for determination of the concentration of BMY-28864by UV/visible spectrophotometry and of the calcium content by atomic absorption spectrometry, respectively.
(2) Molar ratio of Me-Manto BMY-28864in the complex yielded in the presence of 1 mMcalcium chloride at varied BMY-28864concentrations.
Me-Man (250/il; final concentration 50mM), 75, 100, 150 or 200^1 of l.lOmM BMY-28864, 10^1 of 100mMCaCl2 and 665, 640, 590 or 540//I of distilled water were mixed to make 1.0ml mixtures; and allowed to react at 30°C for 30 minutes. After centrifugation at 14,000 rpm for 5 minutes, the supernatants (970 /xl) were removed from the reaction vessels, and the precipitates were dissolved in 970/zl of distilled water containing no calcium. Ahalf-milliliter aliquots were subjected to quantitative analyses of Me-Man and BMY-28864 by the phenol sulfuric acid method20) and UV/visible spectrophotometry, respectively. In the controls, the BMY-28864solution was replaced by distilled water. After incubation followed by centrifugation, 970jA of the supernatant was removed; and the precipitate was mixed with 75~200 ul (final concentration 2mM)and 1,080 /A of distilled water was incubated at 30°C for 30minutes, and then divided into two 1-ml aliquots.
One aliquot was employed for quantitation of the BMY-28864 and calcium contents. After centrifugation at 14,000 rpm for 5 minutes, the precipitate was collected by decantation, rinsed twice with 1 ml each of 200mMMe-Man, and then dissolved in 1.0ml of DMSO.The DMSOsolution was divided into two halves which were used for determination of the calcium and BMY-28864contents by atomic absorption spectrometry and UV/visible spectrophotometry at 498.4 nm, respectively. The other aliquot was centrifuged at 14,000 rpm for 5 minutes and the supernatant (970 fA) was replaced by 970 /xl of distilled water. The aqueous solution was divided into two halves. One half was subjected to the phenol sulfuric acid analysis for quantitation of Me-Man, whereas the other half, after diluted with 0.5 ml of 0.1 n NaOH, was used for spectrophotometric quantitation of BMY-28864.
The no-calcium control contained 20fd of distilled water instead of the calcium chloride solution, and was treated in the same fashion as above to give the 100%control for adsorbed BMY-28864.
The no-BMY-28864control was used to compensate the Me-Mancontent by subtracting the optical density of the disaccharide moiety of BMY-28864, as described above. More particularly, the no-BMY-28864 control contained 400jA of distilled water instead of the BMY-28864 solution. After incubation, the control mixture was centrifuged and the supernatant (970 /xl) was discarded. The remaining content was mixed with 770 /d of distilled water and 200 /il of the BMY-28864 solution, and then subjected to the phenol sulfuric acid analysis, yielding the optical density of Me-Manplus BMY-28864.
Results
Relationship of the Antifungal Activity with the Cell Adsorption of BMY-28864 Macroscopically it is easy to predict which fungi are sensitive to pradimicins, as sensitive strains are stained red with pradimicins on mixing. For further confirmation, the antimicrobial activity and adsorption profiles of BMY-28864were examined for yeasts, fungi and bacteria. Results in Table 1 show that BMY-28864has antifungal activities against yeasts and Trichophyton mentagrophytes, only in the presence NT: Not tested. JAN. 1993 of calcium chloride; and that its antifungal activities are positively correlated with the amounts of BMY-28864adsorbed to freeze-dried cells. Similar results of BMY-28864adsorption were also obtained with intact microorganisms (data not shown).
Essential Role of Calcium in the Cell Adsorption and Potassium Leakage Induction of BMY-28864 It is important to recall that pradimicin derivatives have empirically been shownto express their antifungal activities solely in the presence of calcium by in vitro assays. As the first step for detailed elucidation of the antifungal action of BMY-28864, specificity of calcium ion was comparatively examined with a variety of metal chlorides in the cell adsorption and potassium leakage induction of BMY-28864. Table 2 apparently demonstrates that only calcium chloride among the metal chlorides tested is highly specific in both the yeast cell adsorption and the potassium leakage induction of BMY-28864. Cadmium mayalso have a similar but weaker effect.
Binding Kinetics of BMY-28864to Candida albicans and Saccharomyces cerevisiae Cells If BMY-28864were adsorbed to fungi, the progresses of BMY-28864binding to a variety of yeast cells would be traceable and analysable by binding kinetics.
The kinetic parameters of BMY-28864adsorption to yeast cells are listed in Table 3 , which reveals that Candida albicans A9540 and Saccharomyces cerevisiae ATCC9763 have virtually the same kinetic properties; and that the immobilized yeast cells probably behave in the same manner as the intact cells, in binding of BMY-28864in the presence of calcium chloride. Accordingly, adsorption data of BMY-28864 to dead yeast cells are considered to be reasonably applicable to intact yeast cells.
Adsorption of BMY-28864to Cell Wall Components and Enzymes
in the Presence of Calcium Chloride It is widely acknowledged that the yeast cell wall is composed of mannan, mannoprotein, glucan, chitin, etc.21); and that some enzymes such as invertase also contain small amounts of mannan.21>22) For better characterization of BMY-28864 adsorption to yeast cells, commercially available cell wall Table 2 . Effects of metal chlorides on Candida albicans Table 3 Antagonistic Effects of Hexoses and MannanPreparations on the Antifungal Activity of BMY-28864 As mannan, a polymannosaccharide, abundantly exists on the yeast cell surface, exogenous addition of saccharides in the presence of BMY-28864 and calcium was expected to antagonize the in vitro antifungal activity of BMY-28864 by competitive binding.
Specificities of hexoses and mannan preparations in inhibition of BMY-28864adsorption to yeast cells in the presence of calcium were indirectly compared by antifungal antagonism using Saccharomyces cerevisiae instead of Candida albicans as assay organism, because of technical difficulties in bioassay by the latter. The effect of a sugar is expressed in 50%antagonistic concentration. Table 5 demonstrates that the mannan preparations are good antagonists and over 100 times more antagonistic than the linear and branched polymannosaccharides and Me-Man,whereas monosaccharides such as D-glucose are not antagonistic even at 8mg/ml. As the linear polymannosaccharides tested are derived from Saccharomyces cerevisiae X21 80-1 A5-mnn2, the two-or three-dimensional network or multiple branching structure ofmannan seems important to efficiently adsorb BMY-28864 in the presence of calcium.
Protective Effects of Mannanand Me-Manon Candida albicans Protoplasts in the Presence of BMY-28864 Antagonistic effect of mannan on the in vitro antifungal activity of BMY-28864against Saccharomyces cerevisiae (Table 5) indicates the probable competitive binding of exogenously added mannan and cell wall mannanto BMY-28864. As the cytoplasmic membraneof yeast is also knownto contain mannan, the competition of cytoplasmic membranemannanwith exogenously added mannanin binding to BMY-28864 was examined by the time course of change in stability of Candida albicans protoplasts. Fig. 2 shows that exogenously added mannan and Me-Mansignificantly protect the protoplasts from BMY-28864-dependent lysis by competitive binding to BMY-28864.
Interactions
of BMY-28864with Sugars (1) Specificity of sugars in precipitation of BMY-28864in the presence of 1 mMcalcium chloride. Yeast mannans commonlycontain multiple units of mannose, but greatly differ in components, compositions and linkages.21'24* Although linear polymannosaccharides are far less effective than mannans in antagonism (Table 5 ), the mannose unit was assumed to play a central role in BMY-28864adsorption. Therefore, in the presence of 1 mMcalcium chloride, interactions of BMY-28864with monosaccharides were compared at a sugar concentration of200 mMin 0.6 mKC1, 50 mMMOPS,pH 7.4, and distilled water. Table 6 demonstrates that only D-mannose, Me-Manand D-fructose among the tested hexoses produce precipitates with BMY-28864in the three media. Considered from the high specificity of mannan in BMY-28864 adsorption, it is important to recall that the 3 hexoses listed above share the common configurations at the C-2 and C-4 hydroxyl groups (see Fig. 3 ), whereas 2-amino-mannose, 2-acetylamino-mannose and mannose 6-phosphate form no precipitates with BMY-28864. Clear difference of mannose from glucose and galactose in precipitation with BMY-28864suggests a possibility that the precipitates of BMY-28864with the seemingly specific hexoses such as mannoseand Me-Manmight not be simple mixtures but complexes containing BMY-28864and components at fixed ratios. If this were the case, the adsorption of BMY-28864 to yeast cells in the presence of calcium would be selectively inhibited by the specific hexoses, depending on the degree of binding specificity, as is reported with lectin.25>26) Based on this assumption, the comparative inhibitory effects of fructose, mannose and Me-Man on adsorption of BMY-28864 to immobilized Saccharomyces cerevisiae cells were examined at 200, 100, 50, 25 and 12.5m Results in Table 7 apparently show that 50mM Me-Man,D-mannose and D-fructose significantly inhibit the BMY-28864 adsorption, again support- Me-Man, O BMY-28864 (55 /imol/ml). ing the above-described assumption that BMY-28864might behave like lectin by formation of complexes in the presence of calcium. Amongthe three hexoses, Me-Manseems to be more effective in precipitation with BMY-28864, presumably because of the methyl substituent at C-l. JAN. 1993 Kinetics of Inhibition by Me-Manof BMY-28864Adsorption to Immobilized Saccharomyces cerevisiae Cells in the Presence of 1 mMCalcium Chloride For further confirmation of the working hypothesis that, on binding to the yeast cell wall, BMY-28864 might form a complex with mannan in the presence of calcium, the inhibitory effect of Me-Manon BMY-28864adsorption to the immobilized yeast cells was analysed by the Scatchard plot according to the method of Steck and Wallack.20) Binding profiles of BMY-28864to the yeast cells in the presence and absence of Me-Manare presented in Fig. 4 . Ka values in the presence and absence of Me-Manwere calculated to be 22 and 18/im, respectively, leading to an inhibition constant Ki of about lOOmM in the competitive inhibition mode. Additional evidence for the complex formation of BMY-28864with mannan and Me-Manin the presence of calcium was provided by UVpeak shift from 498 nm to 515 nm before and after mixing. This characteristic UVshift was already reported for benanomicins by S. Kondo et ai21) (For details, see a subsequent paper).
These findings together with above-described observations explicitly indicate the probability that BMY-28864forms a complex with yeast cell wall mannan in the presence of calcium.
Quantitative Component Analysis of the Complex of BMY-28864 with a Specific Sugar in the Presence of Calcium (1) Molar ratio of BMY-28864to calcium in complexes containing the specific sugars. If mixing of BMY-28864with the specific sugars in the presence of calcium resulted in complex formation, on one hand, the molar ratio of BMY-28864 to calcium in the precipitates should remain constant irrespective of the type of the specific sugar. If the precipitate were a simple mixture and not a complex, on the other hand, the molar ratio of BMY-28864 to calcium would freely change depending on the mixing conditions. These two possibilities were examined using precipitates which were yielded from BMY-28864with mannan, Me-Man, mannose and fructose in the presence of calcium chloride. Table 8 clearly reveals that, although the molar content of sugar was not determined, the molar ratio ofBMY-28864 to calcium is constant at 2 : 1 within If the precipitate of BMY-28864 with sugar and calcium chloride were a true complex, changes in the BMY-28864 concentration would also be assumed not to lead to variation in the molar 159 component ratio of BMY-28864to the specific sugar in the precipitate. Using 50mMMe-Manas specific sugar, the molar ratio of Me-Manto BMY-28864was determined in the precipitates which were produced in the presence of 1 mMcalcium chloride at varied BMY-28864 concentrations from 83 fiM to 220 /xm. The results of quantitative analysis are summarized in Table 9 , which also clearly indicates the complex formation of BMY-28864with Me-Manat a molar ratio of 1 : 2.
(3) Analysis of the three components in one and the same ternary complex of BMY-28864with Me-Manand calcium.
The preceding findings revealed that the ternary complex of BMY-28864with sugar and calcium probably had a molar ratio ofBMY-28864 -sugar -calcium of 1 : 2 : 0.5. As this ratio was indirectly calculated based on the separate analytical results from independent experiments, it was essential to directly determine the molar ratio of the three componentsin one and the same preparation of the ternary complex. For determination of the molar ratio of the three components in one and the same complex, 0.22mM BMY-28864 was mixed with 50mMMe-Man (molar mixing ratio = 1 : 227) and 2mMcalcium chloride, and the resulting complex was subjected to the component analysis. The molar component ratio 'of Me-Man: BMY-28864: Ca in this complex was found to be 4.3 (301 nmol) : 2.1 (144nmol): 1.0 (70nmol), which allows to conclude that one mole of calcium binds to 2mol of BMY-28864and 4mol of Me-Man to form the ternary complex.
Discussion
As reported in previous papers,1~6) pradimicin derivatives including BMY-28864which are selectively antifungal and/or antiviral in vitro and in vivo, show no binding affinity to cultured animal cells at all, suggesting the potential application of BMY-28864 (and probably other pradimicin derivatives) to therapy of fungal infections especially in AIDS patients. As immuno-deficiency is very significant in AIDS, the antifungal activity of BMY-28864without affinity to animal cells seems to be of prime value as antifungal agent. In addition, the pradimicin and benanomicin family of antibiotics clearly differ from conventional antifungal agents in calcium dependency and no cross resistance with azole compounds. These features of pradimicin analogs as antifungal agent motivated the authors to study the detailed modeof antifungal action of pradimicins from the biochemical and therapeutic viewpoints.
Recently the definition of lectin, a carbohydrate-binding protein, has been revised jointly by I. R. Goldstein, R. C. Hughes, M. Monsigny, T. Osawa and N. Sharon.28) Interestingly, the results described in this paper clearly show that, although not protein, BMY-28864, which is a semi-synthetic derivative from naturally-occurring pradimicin analogs, is adsorbed to yeast mannanat two sugar-binding sites in the presence of calcium; that the binding of BMY-28864 to yeast mannanis inhibited by specific monosaccharides such as Me-Man, mannose and fructose; and that BMY-28864binds to sugar-specific JAN. 1993 enzymes such as invertase and carboxypeptidase Y, which all perfectly satisfies the essential functional requirements of lectin. Only one, but very critical, contradiction to the above-cited definition of lectin is that the pradimicin is not protein but benzo [a] naphthacenequinone.
Referring to the binding properties of BMY-28864 to Candida as lectin-mimic agent, it is important to indicate that BMY-28864recognizes D-mannose moieties in mannan by the two free hydroxyl groups at C-2 and C-4 ofmannose. Consequently, taken all together, it will be appropriate hereafter to collectively characterize the pradimicin and benanomicin family of compounds as "carbohydrate-recognizing antibiotics".
In Candida albicans, mannan which composes the fibrillar, outer and inner layers of the cell wall, represents about 40% of the total cell wall polysaccharide and plays an important role not only as ligand but also as receptor on the cell surface. As it seems probable that BMY-28864 expresses a potent in vitro and in vivo antifungal activity on yeasts in lectin-mimic mode of binding, a group of pradimicin derivatives will also be valuable as biochemical tools for study of the adherence and receptor activities of Candida albicans and other yeasts.21]
In a subsequent paper, the antifungal and mannan-binding properties of BMY-28864and related analogs will be comparatively analyzed in the light of the ternary complex formation in a lectin-mimic manner.
